RxDoctor Payments Data

Joy Gray

Family · Hixson, TNNPI 1699344176

Payments from drug & device makers

$2,590in general payments, 2019–2025

Across 53 payments — averaging $48.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Epizyme, Inc.$1K
  • GSK$213
  • Novo Nordisk$159
  • Sanofi$132
  • AstraZeneca$109
  • Karyopharm Therapeutics Inc.$75
  • plus $527 from 16 others

What the payments were for

  • Speaking & faculty fees$1,37553%
  • Food & beverage$1,21547%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,590 in reported general payments places this provider in the 80th percentile of 6,706 family providers in Tennessee.

See all family providers in Tennessee

Medicare billing

Part B allowed, 2024
$7,331
Medicare patients
45
Services billed
134

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin22$23,996
Trelegy ElliptaFluticasone/Umeclidin/Vilanter12$7,434
Lantus SolostarInsulin Glargine,hum.Rec.Anlog21$1,717
Albuterol Sulfate HfaAlbuterol Sulfate30$985
Atorvastatin Calcium39$379
Levothyroxine Sodium39$313
Omeprazole35$291
Losartan Potassium21$264
Rosuvastatin Calcium20$224
Amlodipine Besylate46$217
Lisinopril27$202
Metoprolol Succinate14$200
Fluticasone Propionate17$196
Carvedilol14$191
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine12$178

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta$213$7,43412 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 6,706 family providers in Tennessee.

Other family in Hixson

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →